肠促胰岛素
神经保护
胰高血糖素样肽-1
海马体
利拉鲁肽
内科学
受体
内分泌学
神经发生
激素
2型糖尿病
医学
糖尿病
神经科学
生物
作者
Yolanda Diz-Chaves,Salvador Herrera-Pérez,Lucas C. González-Matías,Federico Mallo
标识
DOI:10.1016/bs.vh.2021.12.005
摘要
The glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone very well known for its incretin effect in the glucose-dependent stimulation of insulin secretion. However, GLP-1 is also produced in the brain, and it displays critical roles in neuroprotection by activating the GLP-1 receptor signaling pathways. GLP-1 enhances learning and memory in the hippocampus, promotes neurogenesis, decreases inflammation and apoptosis, modulates reward behavior, and reduces food intake. Its pharmacokinetics have been improved to enhance the peptide's half-life, enhancing exposure and time of action. The GLP-1 agonists are successfully in clinical use for the treatment of type-2 diabetes, obesity, and clinical evaluation for the treatment of neurodegenerative diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI